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a  b  s  t  r  a  c  t
Cross-presentation  of foreign  antigen  in  major  histocompatibility  complex  (MHC)  class  I  by  dendritic
cells  (DCs)  requires  activation  of the  NADPH-oxidase  NOX2  complex.  We  recently  showed  that  NOX2  is
recruited  to phagosomes  by the  SNARE  protein  VAMP8  where  NOX2-produced  reactive  oxygen  species
(ROS)  cause  lipid  oxidation  and  membrane  disruption,  promoting  antigen  translocation  into  the  cytosol
for  cross-presentation.  In this  study,  we extend  these  findings  by showing  that  VAMP8  is  also  involved  in
NOX2  trafficking  to endosomes.  Moreover,  we demonstrate  in  both  human  and  mouse  DCs that  absence
of  VAMP8  leads  to decreased  ROS  production,  lipid  peroxidation  and antigen  translocation,  and  that  this
impairs cross-presentation.  In contrast,  knockdown  of VAMP8  did  not  affect  recruitment  of  MHC  class  I
and the  transporter  associated  with  antigen  processing  1 (TAP1)  to phagosomes,  although  surface  levels
of MHC  class  I were  reduced.  Thus,  in addition  to  a  secretory  role,  VAMP8-mediates  trafficking  of  NOX2
to  endosomes  and  phagosomes  and this  promotes  induction  of  cytolytic  T cell  immune  responses.
© 2017  The  Authors.  Published  by  Elsevier  GmbH.  This  is an  open  access  article  under  the CC
BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/).
1. Introduction
Dendritic cells (DCs) are key antigen presenting cells of the
immune system that take up pathogens by endocytosis and
phagocytosis to kill, degrade and finally present pathogen-derived
antigens for activation of T cells (Cruz et al., 2017; Joffre et al.,
2012; Nair-Gupta and Blander, 2013). Activation of CD8+ ‘killer’
T cells requires ingested antigens to be presented on major histo-
compatibility (MHC) class I molecules following a process called
cross-presentation. Essential for cross-presentation is the NADPH
oxidase NOX2 complex which resides on endosomes and phago-
somes, and produces reactive oxygen species (ROS) within the
endo/phagosomal lumen (Dingjan et al., 2016; Jancic et al., 2007;
Kotsias et al., 2013; Mantegazza et al., 2008; Nunes et al., 2013;
Savina et al., 2006). NOX2 promotes antigen cross-presentation by
three mechanisms. First, ROS production results in alkalization of
the endosomal lumen, thereby inhibiting activation of lysosomal
proteases with low pH optima and preventing excessive antigen
degradation (Jancic et al., 2007; Kotsias et al., 2013; Savina et al.,
∗ Corresponding author at: Radboud University Medical Center, Geert Grooteplein
26–28, 6525 GA, Nijmegen, The Netherlands.
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2006). Second, lysosomal proteases of the cystein cathepsin family
are reversibly oxidized by ROS, which also preserves antigen (Allan
et al., 2014; Hari et al., 2015; Rybicka et al., 2012). Last, we showed
that NOX2-produced ROS oxidize lipids of the endosomal mem-
brane, resulting in membrane disruption and release of antigen
from the endosomal lumen into the cytosol (Dingjan et al., 2016).
Within the cytosol, the antigen becomes accessible to proteaso-
mal  degradation for generation of MHC  class I-compatible peptides
(Cruz et al., 2017; Joffre et al., 2012; Nair-Gupta and Blander, 2013).
Recently, we examined how the integral membrane component
of NOX2, cytochrome b558, which consists of gp91phox and p22phox,
traffics to antigen-containing phagosomes in human blood-isolated
monocyte-derived DCs (Dingjan et al., 2017). We showed that
gp91phox is recruited from the plasma membrane to phagosomes
during their formation. After, or perhaps already during, phago-
some sealing, phagosomal NOX2 is replaced from intracellular
compartments of late endosomal/lysosomal nature and this serves
to replace oxidatively damaged NOX2. The final fusion step that
merges NOX2-containing transport vesicles with the phagosomal
membrane is catalyzed by the complexing of the SNARE proteins
VAMP8 with syntaxin-7 and SNAP23 (Dingjan et al., 2017). In mouse
DCs, this trafficking step is targeted by the intracellular pathogen
Leishmania, which selectively cleaves VAMP8 thereby preventing
http://dx.doi.org/10.1016/j.ejcb.2017.06.007
0171-9335/© 2017 The Authors. Published by Elsevier GmbH. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/
4.0/).
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NOX2 function and cross-presentation and evading immune recog-
nition (Matheoud et al., 2013).
In this study, we sought to determine whether VAMP8 would
also be responsible for trafficking of NOX2 components to
endosomes and whether this would be important for antigen
cross-presentation by human DCs. Our data show that siRNA knock-
down of VAMP8 resulted in impaired recruitment of gp91phox,
but not of MHC  class I and the transporter associated with anti-
gen processing 1 (TAP1), to endosomes and phagosomes in human
blood-derived DCs, corroborating our previous findings (Dingjan
et al., 2017). Moreover, we show that the lack of VAMP8 leads
to reduced formation of endosomal ROS and decreased oxidation
of endosomal components, which in turn blocked the translo-
cation of antigen into the cytosol. VAMP8 knockdown impaired
antigen cross-presentation by human DCs, similar to previous find-
ings with VAMP8-negative mouse DCs (Matheoud et al., 2013).
Finally, our data indicate that VAMP8 is involved in multiple trans-
port routes within DCs, and, in addition to the recruitment of
NOX2 to the antigen-containing compartment, mediates trafficking
of MHC  class I to the plasma membrane. Our study strength-
ens the emerging concept that the replenishment of NOX2 from
late endosomal/lysosomal compartments is important for antigen
cross-presentation and the initiation of cytolytic T cell immune
responses.
2. Material and methods
2.1. Cell culture
Human DCs were derived from peripheral blood mononuclear
cells (PBMCs) obtained from healthy volunteers according to insti-
tutional guidelines and as described previously (Dingjan et al.,
2016). Briefly, monocytes were differentiated into immature DCs
by culturing for 6 days at 37 ◦C, 5% CO2 in the presence of 300 U/ml
interleukin-4 and 450 U/ml GM-CSF in complete RPMI-1640 (con-
taining 10% fetal bovine serum (FBS), 2 mM UltraGlutamine and 1%
Antibiotic-Antimytotic (AA)). Jurkat E6.1 cells were used for the T
cell activation assays with human DCs. These cells contain CD8+
T cell receptors that recognize gp100-peptide (residues 280–288)
in complex with HLA-A2. They were cultured in the presence of
5 ng/ml interleukin-2 in complete RPMI-1640. Mouse bone marrow
derived DCs (BMDCs) from VAMP8-/- mice (JAX strain B6;129S-
Vamp8Gt(OST20346)Lex/J) were differentiated by culturing 7 days in
the presence of 20 ng/ml GM-CSF in RPMI-1640 containing 10% FBS,
2 mM UltraGlutamine, 1% AA and 28 M b-mercaptoethanol.
2.2. siRNA knock-down
DCs were electroporated with siRNA against VAMP8 (mix of 3
siRNAs: 5′-GAGGA AAUGA UCGUG UGCGG AACCU-3′, 5′-GAGGU
GGAGG GAGUU AAGAA UAUUA-3′, 5′-CGACA UCGCA GAAGG
UGGCU CGAAA-3′; ThermoFisher) or with non-targeting stealth
RNAi siRNA Negative Control (NT) siRNA#1 (ThermoFisher) using a
Neon Transfection System (ThermoFisher; 1000 V, 40 ms,  2 pulses)
as described (Baranov et al., 2016; Dingjan et al., 2017, 2016). Cells
were used 48 h post-transfection to ensure maximal knock-down.
To test knock-down efficiency, DCs were lysed with 1% SDS in
10 mM Tris-HCl at pH 6.8 and lysates (20 g total protein) were
ran on 16% Tricine-SDS-PAGE and blotted to PVDF. VAMP8 was
detected with rabbit anti-serum raised against VAMP8 (1:1000
dilution; catalog nr. 104 302, Synaptic Systems) in combination
with goat anti-rabbit conjugated with IRDye 800 (Li-Cor) as sec-
ondary antibody (1:5000).
2.3. Plasmid transfection
DCs were transfected with 8 g of a plasmid encoding human
Rab11a N-terminally fused to GFP (Choudhury et al., 2002) per
1 × 106 cells using a Neon Transfection System (ThermoFisher;
1000 V, 40 ms,  2 pulses) as described (Baranov et al., 2014). Cells
were stimulated with zymosan particles 4 h post-transfection, fol-
lowed by immunostaining with anti-gp91phox.
2.4. Antigen uptake
Uptake of bovine serum albumin (BSA) labeled with Alexa fluor
488 was  measured by incubating DCs with 100 g/ml BSA-Alexa
Fluor 488 (ThermoFisher) and 1 g/ml LPS (Invivogen, catalog num-
ber TLR-eblps; isolated from Escherichia coli 0111:B4, UltraPure) for
different time points. After incubation, the cells were washed and
the percentage of BSA-AF488 positive cells was  measured by flow
cytometry (excitation: 488 nm;  emission: 530/30 nm;  FACS Caliber,
BD biosciences).
2.5. Immunofluorescence
Cells were cultured at 50,000 cells per 12 mm diameter coverslip
in the presence of 4.5 m-sized microspheres (10 beads/cell; Poly-
sciences), ovalbumin conjugated with Alexa Fluor 647 (2.5 g/ml;
OVA; Hyglos, catalog number 321000; endotoxin-free) or Alexa
Fluor 633-labelled zymosan particles (5 particles/cell) in serum-
free RPMI for 1 h at 37 ◦C. Cells were fixed with 4% PFA for
15 min  and permeabilized and blocked with 0.1% saponin in
CLSM-buffer (PBS with 20 mM glycine and 3% BSA) at room tem-
perature. For immunostaining, cells were incubated overnight
at 4 ◦C with rabbit serum anti-VAMP8 (104302, Synaptic Sys-
tems), mouse-IgG1 anti-gp91phox (D162-3, MBL), mouse-IgG1
anti-TAP1 (MABF125, Millipore), mouse-IgG2a anti-HLA class I
(ab7855, Abcam), mouse-IgG2a anti-SEC22 B (sc-101267, Santa
Cruz), mouse-IgG1 anti-ERGIC-53 (ABS300, Enzo) and/or rab-
bit serum anti-Calnexin (ab22595, Abcam) at 1:200 dilution in
CLSM-buffer containing 0.1% saponin. Subsequently, the cells
were washed and incubated with goat anti-rabbit IgG labeled
with Alexa Fluor 568 or 647 and goat anti-mouse IgG labeled
with Alexa Fluor 488 (both Life Technologies) as secondary anti-
bodies at 1:400 dilution. Finally, the cells were washed and
embedded in mounting medium containing 0.01% Trolox (6-
hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid) and 68%
glycerol in 200 mM sodium phosphate buffer at pH 7.5. Cells were
imaged on an Olympus FV1000 confocal laser scanning microscope
with a 60 × 1.35 NA oil immersion objective.
2.6. DC phenotyping
Cells were incubated overnight with or without 1 g/ml LPS,
detached and blocked with human serum. This was followed by
surface staining for 30 min  at 4 ◦C with the following antibodies
for human DCs (all BD Biosciences): PE-labeled anti-HLA-A2 (cata-
log number 558570), anti-HLA-DR (555812), anti-CD11c (333149)
and anti-CD86 (555658), APC-labeled anti-CD86 (555660) and
FITC-labeled anti-CD83 (556910). The following antibodies were
used for mouse DCs: PE-labeled anti-HLA-A2 (114608; Biolegend),
anti-HLA-DR (12-5321-82; eBioscience), anti-CD11c (553802; BD
Biosciences) and anti-CD86 (105008; Biolegend). After washing,
fluorescence intensities were measured by flow cytometry (FACS
Caliber).
Cytokines levels in supernatants of human DCs transfected
with NT or VAMP8 siRNA was  assessed with the Proteome Pro-
filer Human Cytokine Array Kit (ARY005; R&D systems) following
the protocol of the manufacturer, except that the membrane was
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stained with IRDye 800CW Streptavidin and imaged with the
Odyssey CLx Infrared Imaging System (Li-Cor).
2.7. ROS measurements
To measure cellular production of H2O2, we used the Amplex
Red assay as described previously (Dingjan et al., 2016). Briefly,
cells were incubated for 2–4 h in a 96 well plate (100,000 cells/well)
in serum-free RPMI with 2.2 M OVA (Hyglos, endotoxin-free) and
1 g/ml LPS (Invivogen, E. coli 0111:B4). This is UltraPure LPS with-
out contaminants of other bacterial components that can influence
cross-presentation (Wagner and Cresswell, 2012). After incubation,
the medium was changed for serum-free RPMI containing 50 M
Amplex UltraRed reagent (ThermoFisher) and 3 U/ml horseradish
peroxidase (Sigma) and the fluorescence of resorufin (excitation:
530 nm;  emission: 590/30 nm)  was measured every 20 min  during
2 h of subsequent incubation.
Production of superoxide anion was measured with 2′,7′-
dichlorodihydrofluorescein diacetate (H2DCFDA) (ThermoFisher).
Briefly, DCs were washed once with cold PBS, followed by incu-
bation on ice for 30 min  with zymosan particles (5 particles/cell).
After this pulse, the pulse-chase samples were washed 3 times with
cold PBS. Then H2DCFDA was added at a concentration of 10 g/ml
to each sample and fluorescence (excitation: 485/20 nm; emission:
530/30 nm)  was measured after different incubation times using
a CytoFluor II microplate reader (ThermoFisher). Background flu-
orescence was subtracted and samples were normalized to the
amounts of cells as determined by the 3-(4,5-dimethylthiazol-2-
yl)-2,5-diphenyltetrazolium bromide (MTT) assay.
Lipid peroxidation was measured with the BODIPY581/591-
C11 assay as described previously (Dingjan et al., 2016). DCs
were loaded with 2.2 M OVA, 1 g/ml LPS and cultured in the
presence of 1 M BODIPY581/591-C11 (4,4-difluoro-5-(4-phenyl-
1,3-butadienyl)-4-bora-3a,4a-diaza-s-indacene-3-undecanoic
acid; ThermoFisher) in serum-free RPMI for different time points
at room temperature. After incubation, the BODIPY581/591-C11
fluorescence was measured by flow cytometry (excitation: 488 nm;
emission: 530/30 nm;  FACS Caliber). The signal from unstained
cells was subtracted for background correction.
2.8. CCF4/ˇ-lactamase assay
The CCF4/-lactamase assay was performed in Willco petri
dishes according to the protocol of the manufacturer (K1095, Life
Technologies) and as described previously (Dingjan et al., 2016).
Briefly, DCs were incubated with 1 M Substrate Loading Solution
and 1 g/ml LPS as adjuvant for 90 min, then washed and incu-
bated with 1 mg/ml  -lactamase (from Pseudomonas aeruginosa,
expressed in E. coli; L6170, Sigma) and 1 g/ml LPS for 3 h. Cells
were washed again and imaged with a Leica SP8 confocal micro-
scope equipped with a 63 × 1.20 NA water immersion objective
(405 nm excitation; 419–458 nm blue and 504–600 nm green emis-
sion of the coumarin donor and fluorescein acceptor fluorophores,
respectively). The FRET cleavage was calculated as the ratio of the
green over the blue fluorescence intensities. The FRET efficiency of
cells in absence of -lactamase was used as ‘no cleavage’ control.
2.9. Cross-presentation assay
For the T cell activation assay, HLA-A2 positive human DCs
were adhered for 1 h at 37 ◦C in X-vivo medium (Lonza) contain-
ing 2% human serum in 96 wells plates. Cells were then washed
and incubated with gp100 short (10 M gp100 (residues 280–288);
GenScript) or long (100 M gp100 (residues 272–300); JPT) peptide
with T cell receptor stimulation mix  (4 g/ml R-848 and poly(I:C);
Enzo Life Sciences) for 4 h. After incubation, cells were washed and
resuspended in X-vivo medium containing Jurkat E6.1 cells (ratio 1
DC: 2 T cells) and co-cultured for 18 h at 37 ◦C. T cells were stained
with CD69-FITC (1:10; BD biosciences), CD3-APC (1:10; eBio-
sciences) and Propidium Iodide (PI; 0.5 g/ml) and analyzed with
a FACS Calibur (BD biosciences). CD69 surface levels as a measure
of T cell activation were analyzed using FlowJo software and Prism
5. Briefly, cells were gated on viability (PI), followed by gating for
CD3-positive cells, and the CD69 signals were determined. T cell
activation was calculated as the ratio of CD69 positive cells stimu-
lated with long over stimulation with short peptide.
2.10. Statistical analysis
Results of at least three independent experiments were plotted
as raw data or normalized to control cells (100%). All experiments
were assessed using paired Student’s t-tests or two-way ANOVA
(following post-hoc Bonferroni’s test). Two-sided P values <0.05
were considered to be statistically significant (*p < 0.05, **p < 0.01,
***p < 0.001).
3. Results
To investigate the role of VAMP8 in antigen cross-presentation
in human DCs, we  performed siRNA knockdown of VAMP8
in blood-isolated monocyte-derived DCs. We  achieved 79 ± 11%
(average ± S.D. from 9 different donors) knockdown efficiency by
Western blot (Fig. 1A). We also generated bone marrow derived
DCs (BMDCs) from VAMP8-/- mice. VAMP8 is a SNARE protein that
catalyzes various endosomal and secretory membrane fusion steps
and locates to both early and late endosomes as well as to phago-
somes and secretory vesicles (Antonin et al., 2000; Dressel et al.,
2010; Ho et al., 2008; Nagamatsu et al., 2001; Paumet et al., 2000;
Polgár et al., 2002; Pryor et al., 2004). VAMP8 also has a secretory
function in DCs as VAMP8 ablation led to a significant reduction of
the surface levels of MHC  class I in human DCs and of both MHC  class
I and II in mouse DCs (Fig. 1B–C). Moreover, VAMP8 knockdown
resulted in a trend of reduced secretion of interleukin-1 receptor
antagonist (IL-1ra; Fig. 1D–E). These results indicate that VAMP8
could mediate the exocytosis of secretory vesicles containing MHC
molecules and IL-1ra and/or plays a role at upstream trafficking
events.
Recently, we showed that VAMP8 mediates the recruitment
of gp91phox to zymosan-containing phagosomes in human DCs
(Dingjan et al., 2017). Others (Matheoud et al., 2013) showed that
VAMP8 also mediates recruitment of gp91phox to latex beads and
Leishmania-containing phagosomes in mouse DCs. In line with
this, we  observed that siRNA knockdown of VAMP8 resulted in
a reduction of gp91phox recruitment to both latex-bead bearing
phagosomes and OVA-containing endosomes compared to the non-
targeting siRNA control (Fig. 2A–B). Thus, our data show that
VAMP8 mediates the recruitment of gp91phox, the integral mem-
brane component of NOX2, to antigen-containing endosomes and
phagosomes in human DCs, corroborating previous findings in
human and mouse DCs (Dingjan et al., 2017; Matheoud et al., 2013).
Importantly, VAMP8-mediated recruitment of gp91phox seems to
be a general mechanism that does not depend on signaling by
pathogen recognition receptors (PRR), as it was observed for a wide
range of model antigens and also for latex beads that do not activate
PRRs (Fig. 2A–B; Dingjan et al., 2017; Matheoud et al., 2013).
We then tested whether the reduced phagosomal recruitment of
gp91phox upon VAMP8 knockdown would lead to impaired cellular
ROS production. VAMP8-knockdown DCs produced less H2O2 com-
pared to non-targeting siRNA control cells, as measured with the
Amplex Red assay (Fig. 2C). In these experiments, we  stimulated the
DCs with the Toll like receptor 4 (TLR4) agonist lipopolysaccharide
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Fig. 1. Loss of VAMP8 results in decreased surface-levels of MHC class I. (A) siRNA knockdown for VAMP8 in human DCs (VAMP8 KD; NT: non-targeting siRNA; see reference
(Dingjan et al., 2016) for quantification) and VAMP8 expression in BMDCs from VAMP8± and −/− mice by Western blot. GAPDH: loading control. (B) Representative flow
cytometry histograms of surface staining of MHC  class I and II molecules in VAMP8 KD (blue) and NT (green) human DCs (upper graphs) and for VAMP8−/− (blue) and
VAMP8±  (green) mouse BMDCs (lower graphs). The grey curves show the mean fluorescence intensities of the isotype controls. (C) Expression levels of HLA-A2 molecules
(MHC-I), HLA-DR molecules (MHC-II), CD11c or CD86 on the surface of VAMP8 KD human DCs (left) or VAMP8-/- mouse BMDCs (right) normalized to control cells. (D)
Representative dot blot cytokine array blots for NT and VAMP8 KD human DCs. The grey values are proportional to the levels of secreted cytokines. The 4 most abundant
cytokines are indicated: IL-1ra; macrophage migration inhibitory factor (MIF); interleukin-8 (IL-8); Serpin E1. (E) Quantification of the cytokine secretion levels from panel D
normalized to the highest intensities. Results are from at least three donors and plotted as mean ± s.e.m. (For interpretation of the references to colour in this figure legend,
the  reader is referred to the web  version of this article.)
(LPS) O111:B4 from E. coli which results in increased surface lev-
els of the maturation markers MHC  class I, MHC  class II, CD86 and
CD83 (Sup. Fig. 1), and is known to promote the cross-presentation
efficiency of DCs (Wagner and Cresswell, 2012). For our ROS mea-
surements, it did not matter whether the antigen was continuously
present with the DCs or washed away after initial preincubation
at 4 ◦C (where the antigen binds but is not taken up; Sup. Fig.
2A). Previously, VAMP8 was shown to act as a negative regulator
of phagocytosis, because VAMP8-negative mouse DCs showed an
increased phagocytosis while VAMP8 overexpression resulted in
the reverse effect (Ho et al., 2009, 2008). However, for our human
monocyte-derived DCs, we did not observe an effect of VAMP8
on phagocytosis and VAMP8-knockdown DCs ingested zymosan or
latex particles with similar efficiency as control cells. Endocytosis
was also not affected by VAMP8, as the uptake of the model anti-
gen albumin from bovine serum (BSA) labeled with Alexa Fluor 488
by VAMP8-knockdown DCs was  not changed (Sup. Fig. 2B–C). Thus,
we did not observe effects of VAMP8 knockdown on antigen uptake,
indicating that the decreased cellular ROS production in absence of
VAMP8 is likely caused by the impaired trafficking of NOX2 to the
antigen-containing compartment.
ROS react indiscriminately and hence NOX2 activity causes self-
damage by oxidizing endosomal and phagosomal proteins and
lipids within the DC (Allan et al., 2014; Dingjan et al., 2017, 2016;
Hari et al., 2015; Rybicka et al., 2012). We  expected that the absence
of VAMP8 would reduce this damage, since our results show that
siRNA knockdown of VAMP8 results in impaired endosomal and
phagosomal recruitment of gp91phox and reduced ROS produc-
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Fig. 2. VAMP8 is responsible for NOX2 recruitment to endosomes and phagosomes. (A) Representative confocal micrographs showing the recruitment of gp91phox (green in
merge)  to phagosomes containing latex beads by immunofluorescence in VAMP8 KD DCs and control DCs (non-targeting siRNA; NT). Magenta: immunolabeling for VAMP8.
Arrow heads indicate phagosomes positive for gp91phox. The graph shows the quantification by manual counting of gp91phox-positive phagosomes of DCs from 3 individual
donors  (linked by solid lines; p = 0.0067). (B) Same as panel A, but now for ovalbumin-containing endosomes (OVA; magenta; p = 0.0391). Recruitment was quantified from
the  gp91phox signal at OVA-positive compartments relative to the total imaged cell area. (C) H2O2 production by VAMP8 KD DCs (red curve) compared to NT control DCs (black)
measured with the Amplex Red assay. The symbols show the individual donors. (D) Representative flow cytometry histograms of lipid peroxidation sensor BODIPY581/591-
C11  for VAMP8 KD (blue) and NT (green) human DCs (upper graph) and for VAMP8−/− (blue) and VAMP8± (green) mouse BMDCs (lower graph) after 60 min  incubation
with  LPS and OVA. The red curves show the background fluorescence distribution from cells without BODIPY581/591-C11. (E) Percentage of lipid peroxidation over time in
VAMP8 KD (red curve) and NT (black) human DCs. The symbols show the individual donors. (F) Quantification of panel D. Relative lipid peroxidation: mean fluorescence
intensities of VAMP8 KD DCs (4 donors; p = 0.0154) and VAMP8-/- BMDCs (3 mice; p = 0.0474) relative to the NT and VAMP8± controls. Scale bars, 10 m. (For interpretation
of  the references to colour in this figure legend, the reader is referred to the web version of this article.)
tion. To investigate this possibility, we measured peroxidation of
cellular lipids with the lipid peroxidation probe BODIPY581/591-
C11 in human DCs. This probe mimics a poly-unsaturated lipid
and its oxidation results in an increased fluorescence emission at
510 nm that can be measured by flow cytometry (Fig. 2D). Incu-
bating human DCs with this probe revealed time-dependent lipid
peroxidation, and this was reduced in DCs with siRNA knockdown
of VAMP8 compared to DCs transfected with non-targeting siRNA
(Fig. 2E). This reduction in lipid peroxidation was  similar to what
we observed previously with siRNA knockdown of gp91phox, or
upon treatment of the DCs with the NOX2-inhibitor phenylarsine
oxide or the lipophilic radical scavenger -tocopherol (Dingjan
et al., 2016). Lipid peroxidation was also reduced in BMDCs isolated
from VAMP8-/- mice compared to BMDCs from wild-type mice
(Fig. 2F; Kanwar et al., 2008; Matheoud et al., 2013), although in
this case LPS maturation only resulted in increased surface expres-
sion of CD86 and did not affect MHC  class I, MHC  class II and
CD11c levels (Sup. Fig. 1B). These data show that genetic ablation
of VAMP8 results in a significant reduction of lipid peroxidation
in both human and mouse DCs (Fig. 2E–F), further supporting the
requirement of VAMP8 for NOX2 activity.
We recently showed that the oxidation of endosomal lipids pro-
motes the translocation of antigen from the phagosomal lumen
into the cytosol (Dingjan et al., 2016). Since our data showed a
requirement for VAMP8 in NOX2 activity, we  examined whether
the genetic ablation of VAMP8 would block the translocation of
antigen over endosomal membranes. We  used an antigen-leakage
assay based on Förster resonance energy transfer (FRET) with
the probe coumarin-cephalosporin-fluorescein (4)-acetoxymethyl
(CCF4-AM) (Cebrian et al., 2011; Dingjan et al., 2016; Ray et al.,
2010). CCF4 accumulates in the cytosol and can be cleaved by
the enzyme -lactamase, which results in a loss of FRET between
its coumarin (donor) and fluorescein (acceptor) fluorophores.
Mammalian cells do not produce -lactamase, but exogenous -
lactamase can be taken up by DCs and escape from endosomes into
the cytosol where it can cleave CCF4. We performed side-by-side
comparisons where we first loaded VAMP8 knockdown and control
DCs with CCF4 and then cultured them in the presence of exogenous
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Fig. 3. Antigen cross-presentation depends on VAMP8-mediated trafficking of NOX2. (A) Representative confocal microscope images of the CCF4 endosomal leakage assay
for  VAMP8 siRNA knockdown (VAMP8 KD) and non-targeting siRNA (NT) human DCs. The cytosolic FRET probe CCF4 was cleaved by exogenous -lactamase (-lac) resulting
in  a decreased ratio of fluorescein (acceptor fluorophore; green in merge) over coumarin (donor; blue) fluorescence. (B) Representative confocal microscope images as in
panel  A, but now for VAMP8-/- and VAMP8± mouse BMDCs. (C) Quantification of panel A. The graph shows the CCF4 cleavage efficiencies (see reference (Dingjan et al., 2016))
of  DCs from 3 donors (linked by solid lines; p = 0.0312). (D) Same as panel C, but now for VAMP8-/- and VAMP8± mouse BMDCs (panel B; p = 0.0457). (E) Representative
flow  cytometry histograms of CD69 expression by Jurkat cells carrying a gp100-specific T cell receptor. The jurkat T cells were co-cultured with VAMP8 KD (blue) and NT
(green)  DCs that were loaded with short (residues 280–288; left-hand graphs) or long (residues 272–300; right) gp100 peptide. The percentages CD69-positive T cells are
indicated in the graphs. (F) Quantification of T cell activation from panel E for 4 donors (p = 0.0461). Scale bars, 10 m.  (For interpretation of the references to colour in this
figure  legend, the reader is referred to the web  version of this article.)
-lactamase purified from Escherichia coli (Fig. 3A–B). The DCs were
stimulated with LPS in these experiments, although we  cannot
exclude additional PRR-signaling from bacterial contaminants in
the -lactamase. Compared to the control cells, CCF4 cleavage was
reduced both with human DCs with siRNA knockdown of VAMP8
and with mouse VAMP8-/- BMDCs (Fig. 3C–D). Thus, the absence
of VAMP8 leads to reduced antigen translocation over endosomal
membranes.
The release of antigen from endosomes into the cytosol is
well-known to promote antigen cross-presentation by making it
accessible to degradation by the proteasome (Cruz et al., 2017;
Joffre et al., 2012; Nair-Gupta and Blander, 2013). We  therefore
reasoned that the reduced endosomal antigen release we  observed
upon genetic ablation of VAMP8 could well explain known defects
in antigen cross-presentation by BMDCs from VAMP8-/- mice
(Matheoud et al., 2013). To further examine the potential involve-
ment of VAMP8 in cross-presentation, we investigated whether
knockdown of VAMP8 would impair antigen cross-presentation by
human DCs. We  cultured our human DCs with a long peptide of
the melanoma antigen gp100 (residues 272–300). DCs that take
up and process this peptide can cross-present a small fragment
of this peptide (residues 280–288) to a Jurkat T cell line carry-
ing a receptor specific for this fragment (Dingjan et al., 2016). We
also incubated DCs with this short gp100280-288 peptide which can
be directly loaded on MHC  class I and thereby allows to measure
direct presentation. Jurkat T cell activation results in upregulated
expression of the maturation marker CD69 on its surface. Jurkat
T cell activation by VAMP8-knockdown DCs was reduced com-
pared to the non-targeting siRNA control for the long, but not
the short, peptide (Fig. 3E–F). Although this reduction was  rela-
tively small, it was  significant and similar to the inhibitions that
we observed previously by direct siRNA knockdown of gp91phox
or by treatment with the proteasome inhibitors MG132 and lacta-
cystin (Dingjan et al., 2016), which suggests that NOX2 activation
is necessary for cross-presentation via the cytosolic, TAP- and
proteasome-dependent pathway. The decreased T cell activation
upon VAMP8 knockdown was not caused by reduced surface lev-
els of MHC  class I (Fig. 1C) because this reduction was no longer
significant for matured DCs (Sup. Fig. 3) and because direct presen-
tation of the short gp100280-288 peptide was not affected. Together,
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Fig. 4. Recruitment of TAP1 and MHC  class I molecules to phagosomes is VAMP8-independent. (A) Representative confocal micrographs showing the recruitment of TAP1
(green in merge) and VAMP8 (magenta) to zymosan-containing phagosomes by immunofluorescence in VAMP8 KD and NT human DCs. Arrow heads indicate phagosomes
positive for TAP1. The graph shows the quantification by manual counting of TAP1-positive phagosomes of DCs from 3 individual donors. (B) Same as panel A, but now for
MHC  class I (MHC-I; green in merge). Scale bars, 10 m;  ns: not significant. (For interpretation of the references to colour in this figure legend, the reader is referred to the
web  version of this article.)
these data are in accordance with a role for VAMP8 in delivery of
gp91phox to the antigen-containing compartment for antigen cross-
presentation.
In the final set of experiments, we investigated whether the
VAMP8-mediated transport of gp91phox to phagosomes would also
be responsible for the recruitment of other components involved
in antigen cross-presentation. Antigen cross-presentation is pro-
moted by the phagosomal presence of TAP1, an antigen transporter
channel that mainly resides at the endoplasmic reticulum (ER) (Sup.
Fig. 4A; Guermonprez et al., 2003). TAP1 is recruited from the ER
to antigen-containing phagosomes by the action of Sec22b, another
R-SNARE active at the ER-Golgi intermediate compartment (ERGIC;
Sup. Fig. 4B; Cebrian et al., 2011). The phagosomal recruitment of
TAP1 was not affected by knockdown of VAMP8 (Fig. 4A). More-
over, we observed only little, if any, localization of Sec22b to the
phagosome and did not observe overlap between gp91phox and the
ER marker Calnexin (Sup. Fig. 4C–D), indicating that gp91phox and
TAP1 are recruited to the phagosome via different pathways.
We  also tested whether VAMP8 would mediate recruitment
of MHC  class I to phagosomes. MHC  class I molecules are
recruited to phagosomes from Rab11a-positive recycling endoso-
mal  compartments (Nair-Gupta et al., 2014). This is critical for
antigen cross-presentation as Rab11a-silencing reduces MHC  class
I recruitment and results in impaired cross-presentation (Nair-
Gupta et al., 2014). MHC  class I traffics to phagosomes by the action
of the SNARE SNAP23 (Nair-Gupta et al., 2014), which also medi-
ates phagosomal recruitment of gp91phox together with VAMP8
(Dingjan et al., 2017). However, despite that both gp91phox and
MHC  class I traffic to phagosomes by the action of SNAP23 (Dingjan
et al., 2017; Nair-Gupta et al., 2014), VAMP8 does not seem to
mediate phagosomal trafficking of the latter, because genetic abla-
tion of VAMP8 does not affect the recruitment of MHC  class I to
phagosomes in mouse BMDCs (Nair-Gupta et al., 2014). This is
in agreement with our findings, as siRNA knockdown of VAMP8
did not affect phagosomal recruitment of MHC  class I in human
DCs (Fig. 4B), even though part of gp91phox located at Rab11a-
positive recycling endosomal compartments and phagosomes (Sup.
Fig. 4E). Overall, our results and published data (Cebrian et al., 2011;
Nair-Gupta et al., 2014) argue for the independent trafficking of
gp91phox, MHC  class I and TAP1 to the antigen-containing com-
partment, with each of these proteins facilitating the processing of
the antigen for cross-presentation.
4. Discussion
This study is an extension of two  previous studies where
we showed (i) that NOX2-produced ROS induce antigen translo-
cation from endosomes into the cytosol promoting antigen
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Fig. 5. Model of VAMP8-mediated antigen cross-presentation. (step 1) Uptake of antigen via endocytosis or phagocytosis. (2) Recruitment of cytochrome b558 (Cyt b558) to the
antigen-containing compartment by VAMP8, SNAP23 and syntaxin-7. (3) The cytosolic subunits of NOX2 (NOX2cyt; consisting of p40phox, p47phox and p67phox) and the small
GTPase Rac are recruited to cytochrome b558. Fully assembled NOX2 on the phagosome produces ROS in the organellar lumen. (4) ROS lead to disruption of the phagosomal
membrane allowing translocation of antigen into the cytosol. In the cytosol, the antigen becomes accessible for degradation by the proteasome. The proteasome-derived
peptide fragments are imported in the endoplasmatic reticulum (ER) by the transporter associated with antigen processing (TAP) for loading onto MHC class I molecules
(MHC-I). (5) The MHC:peptide complex is transported to the cell surface to cross-present the antigen to naive cytolytic T cells.
cross-presentation (Dingjan et al., 2016) and (ii) that phagosomal
recruitment of the integral membrane component of NOX2 is medi-
ated by the SNARE protein VAMP8 (Dingjan et al., 2017). This study
is also an extension of a recent study by Matheoud et al. (Matheoud
et al., 2013) who showed that gp91phox recruitment to phagosomes
is inhibited in the absence of VAMP8 and that this leads to alkaliza-
tion of the phagosomal lumen, decreased proteolysis and defects
in antigen cross-presentation. In this study, we show that genetic
ablation of VAMP8 in both human and mouse DCs not only impairs
NOX2 recruitment to the antigen-containing compartment, but
also prevents auto-oxidation of endosomal membranes and blocks
endosomal antigen release into the cytosol. Our data support the
previously observed role for VAMP8 in antigen cross-presentation
in mouse DCs (Matheoud et al., 2013), as we show that siRNA knock-
down of VAMP8 leads to impaired antigen cross-presentation in
human DCs.
VAMP8-mediated trafficking of NOX2 to phagosomes seems
independent from the phagosomal recruitment of TAP1 and MHC
class I, two other protein complexes required for antigen cross-
presentation. We  found that whereas VAMP8 knockdown resulted
in reduced recruitment of gp91phox to phagosomes, the phagosomal
presence of TAP1 and MHC  class I were not affected. This finding
data is in line with literature: Nair-Gupta et al. showed that MHC
class I is recruited to phagosomes from Rab11a-positive recycling
endosomes and this recruitment is not affected in DCs from VAMP8-
knockout mice (Nair-Gupta et al., 2014). Cebrian et al. showed that
TAP1 is recruited to phagosomes from the ER-Golgi intermediate
compartment by the action of Sec22b, another R-SNARE (Cebrian
et al., 2011). In contrast, our data and literature (Dingjan et al., 2017;
Matheoud et al., 2013) show that gp91phox is recruited to phago-
somes from compartments of lysosomal nature by the action of
VAMP8. Thus, it is becoming increasingly clear that NOX2 traffics
to phagosomes independent of TAP1 and MHC  class I. NOX2 has a
role early in cross-presentation and promotes the translocation of
antigen into the cytosol and reduces activation of endo/lysosomal
proteases by increased pH and/or reversible oxidation (Allan et al.,
2014; Dingjan et al., 2016; Jancic et al., 2007; Kotsias et al., 2013;
Rybicka et al., 2012; Savina et al., 2006). In addition, NOX2 mediates
the killing of ingested microbes by DCs (Vulcano et al., 2004). TAP1
and MHC  class I play roles later during cross-presentation as they
mediate antigen transport, loading and presentation (Cruz et al.,
2017; Joffre et al., 2012; Nair-Gupta and Blander, 2013). The inde-
pendent trafficking of NOX2 to antigen-containing compartments
might allow to uncouple ROS production from these later functions
and thereby could allow better spatial and/or temporal control of
antigen processing and presentation.
The defects we  observed in endosomal antigen release and
cross-presentation upon genetic ablation of VAMP8 are relatively
mild. This is likely caused by the fact that not all gp91phox traffics
to the antigen containing compartment by the action of VAMP8,
but that part of gp91phox reaches the phagosome from the plasma
membrane during antigen internalization (Dingjan et al., 2017).
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Another likely explanation for the relatively small effects of VAMP8
knockdown/knockout is that SNARE proteins are redundant and
promiscuous and other SNARE proteins may  at least partially com-
pensate for the absence of VAMP8. Indeed, in many studies the
knockdown or knockout of SNARE proteins did not result in clear
changes in phenotype (Bethani et al., 2009; Hong, 2005; Nair-Gupta
et al., 2014). Moreover, we found relatively mild phenotypes of
a ∼25% reduction of surface expressed MHC  class I and a trend
towards lower IL-1ra secretion upon VAMP8 knockdown in human
DCs. A key candidate for such a compensatory role is VAMP3,
which locates to endosomes and phagosomes similar to VAMP8
(Matheoud et al., 2013; Nair-Gupta et al., 2014; Verboogen et al.,
2017). The observed differences in antigen presentation might also
be relatively small, because the absence of VAMP8 does not influ-
ence phagosomal recruitment of MHC  class I and TAP1 and part of
the cross-presentation machinery remains intact.
Our data support the following model of how VAMP8 promotes
antigen cross-presentation by DCs (Fig. 5). First, foreign antigen
is ingested by the DCs. Second, gp91phox traffics to the antigen-
containing compartment by the concerted action of VAMP8,
SNAP23 and syntaxin-7 (Dingjan et al., 2017). Third, NOX2 assem-
bles on the antigen-containing compartment and produces ROS in
the organellar lumen. These ROS lead to an increase of the luminal
pH as well as to auto-oxidation of endo/lysosomal proteases and
of the endo/phagosomal membranes. Fourth, the auto-oxidation
disrupts the membrane integrity, allowing the translocation of anti-
gen into the cytosol, where it becomes accessible to proteasomal
degradation. In the final step, the proteasome-derived peptide frag-
ments can either be re-imported into the endosomes/phagosomes
or be imported in the endoplasmatic reticulum by the transporter
associated with antigen processing (TAP) for loading onto MHC
class I molecules (Cruz et al., 2017; Joffre et al., 2012; Nair-Gupta
and Blander, 2013). In addition to the SNARE molecules VAMP8,
SNAP23 and syntaxin-7 (Dingjan et al., 2017), previous studies
have identified several key molecules for regulating the deliv-
ery of gp91phox to the antigen-containing compartment. One of
these molecules is synaptotagmin 11 which mediates the deliv-
ery of gp91phox to phagosomes in RAW264.7 macrophages (Arango
Duque et al., 2013). Another key protein is the small GTPase Rab27a
which is necessary for efficient recruitment of gp91phox to phago-
somes in mouse BMDCs (Jancic et al., 2007). Our data show that
both these proteins are expressed in human DCs (not shown) and
it seems likely that these proteins regulate the delivery of gp91phox
to the antigen containing compartment also in these cells. If and
by which mechanism synaptotagmin 11 and Rab27a regulate the
SNARE complexing of VAMP8 with SNAP23 and sytaxin-7 remains
to be elucidated. Overall, our results strengthen the emerging con-
cept that the intracellular trafficking of the integral component of
NOX2 to phagosomes is a key regulatory mechanism for antigen
cross-presentation.
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